Clinical Trial Update: An Open-label, Randomized, and Comparative Study to Evaluate the Efficacy and Safety of Cefoperazone/Sulbactam in Comparison to Cefepime for the Treatment of Hospital-acquired Pneumonia and Healthcare-associated Pneumonia

View source ↗

Summary

An open-label randomized trial compares cefoperazone/sulbactam to cefepime for the treatment of hospital-acquired pneumonia and healthcare-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthcare-associated Pneumonia
• Hospital-acquired Pneumonia

Drugs mentioned

• Cefepime (cefepime)
• Cefoperazone/Sulbactam (cefoperazone/sulbactam)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Pneumonia | Status: UNKNOWN